Targeted Antagonism of Vascular Endothelial Growth Factor Reduces Mortality of Mice with Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is associated with a mortality of 45%. Our previous research indicated that anti-vascular endothelial growth factor (VEGF) could maintain the normal structure and function of the respiratory barrier. However, systemic application of VEGF antagonists would l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhao, Lu, Dong-shi, Zhang, Dan-qing, Wang, Xin, Ming, Yu, Wu, Zhou-yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Huazhong University of Science and Technology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456355/
https://www.ncbi.nlm.nih.gov/pubmed/32862377
http://dx.doi.org/10.1007/s11596-020-2236-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456355/
https://www.ncbi.nlm.nih.gov/pubmed/32862377
http://dx.doi.org/10.1007/s11596-020-2236-7

Ejemplares similares